Delic Corp’s Main Work: A Simple Breakdown

Delic Corp brings psychedelic wellness to life

You may have heard about psychedelic medicine in the news. Delic Corp Holdings makes it real. You see clinics, labs, media events, and research all working together. This company builds a full system around healing with new medicines. You get more than hype—you get real efforts to change mental health care. 

Delic Corp Holdings has grown rapidly since 2018 and now operates clinics, research labs, media platforms, and live events. It is listed publicly under Delic Holdings Corp (also known as DELCF) on the OTC markets in the US and was previously listed on the Canadian Securities Exchange.

What the company does

Below is a discussion of their four main areas of work. We believe these are important for you to know. The areas are

1. Ketamine Clinics
   Delic runs a chain of ketamine wellness centers. They treat depression, anxiety and chronic pain. They offer therapy combined with medication. They aim to bring long term relief not just cover symptoms (Delic Corp, MarketScreener).
2. Delic Labs
   They develop new delivery methods for psilocybin. Think vaporization tech that could deliver spores in safe doses (MarketScreener, Nasdaq).
3. Media Platforms
   Meet Delic events, Reality Sandwich and Delic Radio inform the public. They host conversations on psychedelics. They include e-commerce and educational content (MarketScreener).
4. Live Events
   Meet Delic brings people together to learn and discuss psychedelic medicine. They reach patients, researchers and investors (LinkedIn).

These pillars work together. The media drives awareness. Labs push science. Clinics deliver care. Events build community. That ecosystem supports growth.

Why it matters

Mental health suffers in private for many. You may know someone facing anxiety, depression and chronic pain. People resort to daily pills that only treat symptoms.

Delic aims for deeper work. Clinics help you explore emotional roots. Research labs explore new methods. Media and events put stories into public view. That can ease stigma. That can move medicine forward.

Growth and scale

Delic holds over 100 clinics across North America (Delic Corp, Nasdaq). They report profits. They plan to add more clinics quickly (Delic Corp, Canadian Securities Exchange).

Their financials show net income around one hundred thousand USD in 2021 and revenue several million USD (MarketScreener). They operate with a tight structure. They own each part of their ecosystem (Canadian Securities Exchange, MarketScreener). That gives them control of quality and cost.

They also raised funding via public markets. They went public in November 2020 on the Canadian Securities Exchange (Canadian Securities Exchange).

What you get as a patient

You visit a ketamine wellness center. You go through evaluations therapy sessions and IV‑infusion treatment. Staff monitor you carefully.

You receive preparation guidance therapy aftercare support. You listen to music in a safe setting. You reflect on emotional themes. That process helps treat root causes, not hide them.

Delic values safety. Clinics follow medical best practice. Therapists help you integrate insights after treatment.

Their lab work matters

Delic Labs works on better psilocybin delivery. Their goal: precise dosing fast effect low risk. They design new tools and devices to meet regulators and patients.

They share findings with universities and research groups. They file patents and publish results. That adds credibility to psychedelic medicine.

Media changes perception

Meet Delic events bring together people who share personal stories. Reality Sandwich articles explore science and history. Delic Radio interviews researchers practitioners and patients.

You get stories that stick. That changes how you feel about these medicines.

That media also raises awareness of new clinics and treatments. It feeds interest and trust.

What sets Delic apart

• They own all parts of the system. That gives consistent quality
• They run clinics that earn profits now
• They push research for real innovations
• They build public trust with content and events

You will find that mix rare. Many companies focus on one area. Delic covers clinics research media and events.

They hire experts in each field. Their team includes scientists, therapists, marketers and operators. That helps them stay steady as they grow.

Challenges ahead

Psychedelic medicine still faces legal limits. Many treatments look promising but need FDA approval in the US. Insurance rarely covers these sessions.

Delic must navigate regulations and prove long term safety and efficacy.

They also need skilled staff to run clinics. Training therapists and clinicians takes time and money.

They must show financial returns to keep investors happy. But they operate clinics now and show revenue and profit in some periods (MarketScreener).

How they will grow

You can expect three paths:

1. Add more clinics in new states and provinces
   
2. Advance lab trials to bring new delivery tools
   
3. Host more live events and digital content globally
   

They also may partner with universities or major hospitals. That would speed clinical trials and regulatory approval.

What it means for you

If you face mental health challenges you will see more access. You may soon have a Delic clinic near you.

If you research delivery tech you can follow Delic Labs. If you want to explore alternative treatments you may hear about events or podcasts by them.

If you invest in wellness you can track their stock symbol DELCF. It trades OTC in the US. You can study their revenue and growth (Yahoo Finance, Canadian Securities Exchange, MarketScreener).

FAQs

What is Delic Corp?

Delic Corp is a psychedelic wellness company. It runs clinics, labs, media channels and events in North America aiming to make treatments more accessible.

Where did they start?

They formed around 2018. They went public in Canada in November 2020 (Canadian Securities Exchange).

What treatments do they offer?

Their clinics use ketamine infusion and therapy. Labs work on psilocybin delivery tools. Media and events support education.

Is their treatment covered by insurance?

Mostly no. Some clinics may bill out of pocket. Focus lies on patient affordability and financial sustainability.

Is psychedelic treatment safe?

Ketamine is legal and widely used. Psilocybin sits in clinical trials. Delic follows medical standards in clinics and research.

Can I invest in Delic?

Yes. You can invest in Delic Holdings Corp trading under DELCF OTC. It also listed in Canada earlier (Canadian Securities Exchange).

Are they profitable?

They reported net income near USD 131 000 in 2021 with revenue of USD 3–4 million (MarketScreener). That shows steady growth.